Behavior 149 (2015): 149–58.
16. Riaz Memon et al., “Infection and Inflammation Induce
LDL Oxidation In Vivo,” Arteriosclerosis, Thrombosis,
and Vascular Biology 20 (2000): 1536–42.
17. A. C. Vreugdenhil et al., “LPS-Binding Protein
Circulates in Association with ApoB-Containing
Lipoproteins and Enhances Endotoxin-LDL/VLDL
Interaction,” Journal of Clinical Investigation 107, no. 2
(2001): 225–34.
18. B. M. Charalambous et al., “Role of Bacterial Endotoxin
in Chronic Heart Failure: The Gut of the Matter,” Shock
28, no. 1 (2007): 15–23.
19. Stephen Bischoff et al., “Intestinal Permeability—A
New Target for Disease Prevention and Therapy,” BMC
Gastroenterology 14 (2014): 189.
20. C. U. Choi et al., “Statins Do Not Decrease Small,
Dense Low-Density Lipoprotein,” Texas Heart Institute
Journal 37, no. 4 (2010): 421–28.
21. Melinda Wenner Moyer, “It’s Not Dementia, It’s Your
Heart Medication: Cholesterol Drugs and Memory,”
Scientific American, September 1, 2010,
https://www.scientifi camerican.com/article/its-not-
dementia-its-your-heart-medication/.
22. “Coenzyme Q10,” Linus Pauling Institute—
Macronutrient Information Center, Oregon State
University, http://lpi.oregonstate.edu/mic/dietary-
factors/coenzyme-Q10.
23. I. Mansi et al., “Statins and New-Onset Diabetes
Mellitus and Diabetic Complications: A Retrospective
Cohort Study of US Healthy Adults,” Journal of
john hannent
(John Hannent)
#1